Search
Displaying 231–240 of 737 for “retinitis clinical trial”
-
A Steady Hand in Saving Vision
Research NewsSubretinal injection is the most common form of delivery for gene therapies currently in clinical trials.
-
ARVO 2016: What Does It Take to Develop a Stem-Cell Therapy for the Retina?
Research NewsThere are innumerable considerations for researchers developing therapies.
-
Low-Hanging Fruit: Repurposing Drugs to Treat Retinal Diseases
Research NewsBecause repurposing relies on prior research and clinical data, it reduces the cost and time needed to establish a new therapeutic application for the drug.
-
Curing Blindness, Part 1: Corey’s Story
Beacon StoriesHow gene therapy restored some of a boy’s sight.
-
José-Alain Sahel Awarded 2026 ARVO Proctor Medal for Groundbreaking Research Achievements
Research NewsDr. Sahel’s research has led to several emerging retinal disease therapies that have moved into clinical trials.
-
Foundation News
The free, online event at 7 p.m. ET on March 13, 2025, will feature presentations from Christine Kay, MD, Vitreoretinal Associates in Gainesville, Florida, and Thomas Mendel, MD, PhD, Ohio State University Wexner Medical Center.
-
SparingVision to Acquire Therapy for Resurrecting Dormant Cones for Vision Restoration
Research NewsThe gene-agnostic approach shows promise for people with late-stage RP and related diseases.
-
jCyte Enters into Licensing Agreement with Santen Pharmaceutical for Cell Therapy
Research NewsEmerging treatment designed to preserve vision for people with RP and related conditions
-
SparingVision Gets EU Funding Boost for Development of Cross-Cutting Gene Therapy
Research NewsA clinical trial for the treatment, designed to preserve cone photoreceptors, is planned in the US and Europe in 2020.
-
Disease
Often diagnosed in childhood or adolescence, Usher syndrome is an inherited disease causing combined hearing loss and vision loss from retinitis pigmentosa. The condition can also cause problems with balance.
.png)
